TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric

Jessica A Pollard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.